| Literature DB >> 35628785 |
Chengbao Duan1,2, Shiyuan Wang1,2, Ruiyun Huo1,2, Erwei Li3, Min Wang4, Jinwei Ren1, Yuanyuan Pan1, Ling Liu1,2, Gang Liu1,2.
Abstract
Sorbicillinoids are a class of structurally diverse hexaketide metabolites with good biological activities. To explore new structural sorbicillinoids and their bioactivities, the marine-derived fungus Acremonium chrysogenum C10 was studied. Three new sorbicillinoid derivatives, acresorbicillinols A-C (1-3), along with five known ones, trichotetronine (4), trichodimerol (5), demethyltrichodimerol (6), trichopyrone (7) and oxosorbicillinol (8), were isolated. The structures of new sorbicillinoids were elucidated by analysis of nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectroscopy (HRESIMS). The absolute configurations of compounds 1-3 were determined by comparison of the experimental and calculated electronic circular dichroism (ECD) spectra. Compound 3 exhibited a strong 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, with the IC50 value ranging from 11.53 ± 1.53 to 60.29 ± 6.28 μM in 24 h. Additionally, compounds 2 and 3 showed moderate activities against Staphylococcus aureus and Cryptococcus neoformans, with IC50 values of 86.93 ± 1.72 and 69.06 ± 10.50 μM, respectively. The boundary of sorbicillinoid biosynthetic gene cluster in A. chrysogenum was confirmed by transcriptional analysis, and the biosynthetic pathway of compounds 1-8 was also proposed. In summary, our results indicated that A. chrysogenum is an important reservoir of sorbicillinoid derivatives, and compound 3 has the potential for new natural agents in DPPH radical scavenging.Entities:
Keywords: Acremonium chrysogenum; DPPH radical scavenging activity; antimicrobial compounds; marine natural products; sorbicillinoids; structure elucidation
Year: 2022 PMID: 35628785 PMCID: PMC9144096 DOI: 10.3390/jof8050530
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Structures of compounds 1–8.
1H NMR (500 MHz) and 13C NMR data (125 MHz) for 1 and 2.
| Position | 1 a | 2 a | ||
|---|---|---|---|---|
|
|
| |||
| 1 | 70.3, qC | 66.7, qC | ||
| 2 | 200.3, qC | 199.7, qC | ||
| 3 | 112.3, qC | 113.8, qC | ||
| 4 | 3.18, t (2.8) | 41.5, CH | 3.30, t (2.7) | 42.3, CH |
| 5 | 75.4, qC | 75.2, qC | ||
| 6 | 212.3, qC | 211.4, qC | ||
| 7 | 47.8, qC | 3.09, dd (10.6, 6.1) | 47.5, CH | |
| 8a | 2.38, m | 30.6, CH2 | 3.00, ddd (13.6, 10.6, 2.7) | 32.7, CH2 |
| 8b | 1.97, dd (13.3, 2.8) | 1.80, ddd (13.6, 6.1, 2.7) | ||
| 9 | 167.6, qC | 167.7, qC | ||
| 10 | 6.42, d (14.6) | 119.5, CH | 6.48, d (14.6) | 119.6, CH |
| 11 | 7.26, dd (14.6, 10.9) | 142.9, CH | 7.37, dd (14.6, 11.0) | 143.3, CH |
| 12 | 6.39, dd (14.6, 10.9) | 132.3, CH | 6.41, dd (14.6, 11.0) | 132.3, CH |
| 13 | 6.20, dq (14.6, 7.0) | 140.0, CH | 6.23, dq (14.6, 7.0) | 140.1, CH |
| 14 | 1.89, d (7.0) | 18.9, CH3 | 1.90, d (7.0) | 18.9, CH3 |
| 15a | 1.81, td (13.2, 4.8) | 34.1, CH2 | 133.9, qC | |
| 16 | 2.16, m | 31.4, CH2 | 6.80, d (8.4) | 130.5, CH |
| 17 | 178.3, qC | 6.67, d (8.4) | 116.2, CH | |
| 18 | 5.18, d (15.6) | 135.4, CH | 157.7, qC | |
| 19 | 5.13, dd (15.6, 9.0) | 135.9, CH | 6.67, d (8.4) | 116.2, CH |
| 20 | 1.68, m | 50.6, CH | 6.80, d (8.4) | 130.5, CH |
| 21a | 1.64, m | 27.2, CH2 | 0.80, s | 11.4, CH3 |
| 22a | 2.42, m | 42.4, CH2 | 1.21, s | 24.0, CH3 |
| 23 | 212.4, qC | |||
| 24 | 2.16, s | 30.0, CH3 | ||
| 25 | 1.54, m | 33.4, CH | ||
| 26 | 0.86, d (7.0) | 21.2, CH3 | ||
| 27 | 0.81, d (7.0) | 19.7, CH3 | ||
| 28 | 1.16, s | 7.4, CH3 | ||
| 29 | 1.12, s | 24.5, CH3 | ||
a Recorded in CD3OD.
1H NMR (500 MHz) and 13C NMR data (125 MHz) for 3.
| Position | 3 b | |
|---|---|---|
|
| ||
| 1 | 3.71, s | 53.9, CH |
| 2 | 78.2, qC | |
| 3 | 107.8, qC | |
| 4 | 59.2, qC | |
| 5 | 190.9, qC | |
| 6 | 100.6, qC | |
| 7 | 167.9, qC | |
| 8 | 6.49, d (14.6) | 120.6, CH |
| 9 | 7.12, dd (14.6, 10.9) | 137.8, CH |
| 10 | 6.38, overlap | 131.1, CH |
| 11 | 6.10, (14.6, 6.8) | 136.2, CH |
| 12 | 1.83, d (6.8) | 18.4, CH3 |
| 13 | 1.30, s | 25.2, CH3 |
| 14 | 1.29, s | 18.8, CH3 |
| 1’ | 78.3, qC | |
| 2’ | 78.7, qC | |
| 3’ | 103.5, qC | |
| 4’ | 59.2, qC | |
| 5’ | 199.3, qC | |
| 6’ | 108.0, qC | |
| 7’ | 185.2, qC | |
| 8’ | 7.38, d (14.6) | 122.4, CH |
| 9’ | 7.48, dd (14.6, 10.9) | 146.5, CH |
| 10’ | 6.38, overlap | 131.1, CH |
| 11’ | 6.42, overlap | 143.4, CH |
| 12’ | 1.89, d (6.8) | 18.3, CH3 |
| 13’ | 1.17, s | 22.2, CH3 |
| 14’ | 1.31, s | 18.8, CH3 |
| OH-7 | 16.38, s | |
| OH-7’ | 18.02, s | |
b Recorded in DMSO:CDCl3 = 3:1.
Figure 2Key COSY and HMBC correlations of compounds 1–3.
Figure 3Key NOESY correlations of compounds 1–3.
Figure 4Calculated and experimental ECD spectra of compounds 1–3.
Anti-microbial inhibitory activities of compounds 1–8.
| Compounds |
|
|
|---|---|---|
| IC50 (μM) | ||
|
| >100 | >100 |
|
| 86.93 ± 1.72 | >100 |
|
| >100 | 69.06 ± 10.50 |
|
| >100 | >100 |
|
| >100 | >100 |
|
| >100 | >100 |
|
| >100 | >100 |
|
| >100 | >100 |
|
| 0.016 ± 0.004 | – |
|
| – | 0.018 ± 0.003 |
Figure 5DPPH radical scavenging activity of compound 3 and ascorbic acid as the positive control at 0.5, 1, 4, 6, 8 and 24 h.
DPPH radical scavenging activities of compounds 1–8.
| Compounds | IC50 Value (μM) | |||||
|---|---|---|---|---|---|---|
| 0.5 h | 1 h | 4 h | 6 h | 8 h | 24 h | |
|
| >200 | >200 | >200 | >200 | >200 | >200 |
|
| >200 | >200 | >200 | >200 | >200 | >200 |
|
| 60.29 ± 6.28 | 43.52 ± 5.93 | 22.57 ± 7.34 | 15.85 ± 5.94 | 12.30 ± 5.74 | 11.53 ± 1.53 |
|
| >200 | >200 | >200 | >200 | >200 | 151.87 ± 15.63 |
|
| >200 | >200 | >200 | >200 | >200 | 116.83 ± 3.93 |
|
| >200 | >200 | >200 | >200 | 197.73 ± 27.70 | 102.48 ± 5.04 |
|
| >200 | >200 | >200 | >200 | >200 | >200 |
|
| 155.40 ± 12.42 | 129.87 ± 12.09 | 88.38 ± 16.29 | 77.20 ± 15.38 | 71.00 ± 14.56 | 55.36 ± 14.92 |
|
| 25.36 ± 3.82 | 25.42 ± 3.85 | 26.65 ± 3.29 | 26.77 ± 3.24 | 26.48 ± 4.03 | 28.45 ± 3.04 |
Figure 6(A) Organization of the sorbicillinoid biosynthetic gene cluster. FMO, FAD-dependent monooxygenase; PKS, polyketide synthase; TF, transcriptional factor; AM, auxiliary modifier; MFS, major facilitator superfamily transporter. (B) Transcriptional profiles of the Acsor genes during fermentation.
Figure 7Proposed biosynthetic pathway of compounds 1–8.